Intended for healthcare professionals

  1. Research
  2. Net benefit approaches...
  3. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
CCBYNC Open access
Research Methods & Reporting

Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i6 (Published 25 January 2016) Cite this as: BMJ 2016;352:i6

Data supplement

Related articles

See more

Cited by...

  • Developing clinical prediction models: a step-by-step guide
  • Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study
  • Personalised risk prediction tools for cryptococcal meningitis mortality to guide treatment stratification; a pooled analysis of two randomised-controlled trials
  • Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer
  • Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study
  • Suicide risk assessment tools and prediction models: new evidence, methodological innovations, outdated criticisms
  • Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study
  • Evaluation of clinical prediction models (part 2): how to undertake an external validation study
  • Natriuretic Peptides Improve Classification of People at Low Risk of Atrial Fibrillation after Stroke
  • Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review
  • Predicting falls-related admissions in older adults in Alberta, Canada: a machine-learning falls prevention tool developed using population administrative health data
  • Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
  • The ADNEX risk prediction model for ovarian cancer diagnosis: A systematic review and meta-analysis of external validation studies
  • Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
  • Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study
  • Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
  • Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate Cancer
  • Noninvasive Staging of Lymph Node Status (NILS) in Breast Cancer using Machine Learning: External Validation and Further Model Development
  • Defining the role of host biomarkers in the diagnosis and prognosis of childhood pneumonia - a prospective cohort study
  • External validation and updating of clinical severity scores to guide referral of young children with acute respiratory infections in resource-limited primary care settings
  • Selective prediction for extracting unstructured clinical data
  • Canadian Anaphylaxis Network-Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): a prospective, cohort study protocol
  • Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
  • Predictive models for musculoskeletal injury risk: why statistical approach makes all the difference
  • Predicting the future risk of lung cancer: development and validation of QCancer2 (10-year risk) lung model and evaluating the model performance of nine prediction models
  • Validation of prediction models in the presence of competing risks: a guide through modern methods
  • Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study
  • Performance of the Hull Salford Cambridge Decision Rule (HSC DR) for early discharge of patients with findings on CT scan of the brain: a CENTER-TBI validation study
  • Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia
  • On the 12th Day of Christmas, a Statistician Sent to Me . . .
  • OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
  • From clinical trials to clinical practice: how should we design and evaluate prediction models in the care of IBD?
  • Clinical judgement of General Practitioners for the diagnosis of dementia: a diagnostic test accuracy study
  • Antigen-based rapid diagnostic testing or alternatives for diagnosis of symptomatic COVID-19: A simulation-based net benefit analysis
  • Clinical Utility of Automatable Prediction Models for Improving Palliative and End-Of-Life Care Outcomes: Towards Routine Decision Analysis Before Implementation
  • Large-scale validation of the Prediction model Risk Of Bias ASsessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination
  • Performing risk stratification for COVID-19 when individual level data is not available - the experience of a large healthcare organization
  • Accuracy of signs, symptoms and blood tests for diagnosing acute bacterial rhinosinusitis and CT-confirmed acute rhinosinusitis in adults: protocol of an individual patient data meta-analysis
  • Pre-season screening currently has no value for injury prediction: The development and internal validation of a multivariable prognostic model to predict indirect muscle injury risk in elite football (soccer) players
  • Predicting Residual Function in Hemodialysis and Hemodiafiltration - A Population Kinetic, Decision Analytic Approach
  • COVID-19 prediction models should adhere to methodological and reporting standards
  • Praise to Robust Prediction Modeling in Large Datasets
  • Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing
  • Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study
  • Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal
  • A guide to systematic review and meta-analysis of prognostic factor studies
  • Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
  • Development and prospective external validation of a tool to predict poor recovery at 9 months after acute ankle sprain in UK emergency departments: the SPRAINED prognostic model
  • External validation of computed tomography decision rules for minor head injury: prospective, multicentre cohort study in the Netherlands
  • Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath
  • Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
  • Open reduction and internal fixation of humeral shaft fractures versus conservative treatment with a functional brace: a study protocol of a randomised controlled trial embedded in a cohort
  • A guide to systematic review and meta-analysis of prediction model performance
  • Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study
Back to top